Search Results - "Shaposhnikova, A. N."

Diagnostic value of serum markers of fibrosis in chronic liver diseases by Vinnitskaia, E V, Drozdov, V N, Iunusova, Iu M, Varvanina, G G, Shaposhnikova, N A, Petrakov, A V, Tkachenko, E V, Lazebnik, L B

“…To estimate the diagnostic value (DV) of direct markers of liver fibrosis, such as type IV collagen (C-IV), hyaluronic acid (HA), tissue inhibitor of…”
Get full text

THE HEPATOPROTECTOR ROPREN FOR THE TREATMENT OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: A PROSPECTIVE OBSERVATIONAL STUDY by Golovanova, E V, Shaposhnikova, N A, Melkina, E S, Soultanov, V S

“…New and effective drugs to improve liver function and fibrosis are urgently needed for patients with nonalcoholic steatohepatitis (NASH). This study examines…”
Get more information

The clinical significance of hereditary and acquired alpha-1-antitrypsin deficiency in patients with liver cirrhosis and Wilson-Konovalov disease by Shaposhnikova, N A, Shuliat'ev, I S, Varvanina, G G, Drozdov, V N

Get more information

Synthesis of O-[2-hydroxy-3-(vinyloxy)propyl]oximes and O-[(2-methyl-1,3-dioxolan-4-yl)methyl]oximes by Kukharev, B. F., Stankevich, V. K., Klimenko, G. R., Shaposhnikova, A. N.

“…By oximes reaction with glycidyl vinyl ether O-[2-hydroxy-3-(vinyloxy)propyl]oximes of ketones and acetaldehyde were synthesized in 54–72% yield, and by acid…”
Get full text

The diagnostic significance of ultrasound elastometry in evaluation of fibrosis in chronic diffuse liver diseases by Lazebnik, L B, Vinnitskaia, E V, Shaposhnikova, N A, Khomeriki, S G, Nikanorov, A V, Terekhin, A A, Vorob'eva, N N, Golovanova, E V

“…Determination of the diagnostic value of ultrasound elastometry of liver (UEL) in the assessment of liver fibrosis in patients with chronic diffuse liver…”
Get more information

Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis by Shaposhnikova, N A

Get more information

Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses by Shaposhnikova, N A, Drozdov, V N, Petrakov, A V, Sil'vestrova, S Iu

“…Zinc plays an important role in human physiologic processes being cofactor of many enzymes, it participates in numerous enzyme reactions. We have investigated…”
Get more information

Replicative activity of hepatitis B as a factor determining the progression of liver fibrosis and cirrhosis by Drozdov, V N, Vinnitskaia, E V, Shuliat'eva, I S, Shaposhnikova, N A, Borunova, Zh V

Get more information

WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION, DYSTROPHIA HEPATOCEREBRALIS) DIAGNOSIS, TREATMENT AND DISPENSARY OBSERVATION. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015 by Golovanova, E V, Lazebnik, L B, Konev, Yu V, Shaposhnikova, N A

“…Wilson's disease (hepatolenticular degeneration, dystrophia hepatocerebralis)--a chronic, progressive disease with a genetically determined autosomal recessive…”
Get more information

Treatment and prevention of portal hypertension in patients at elderly and senile patients by Koviazina, I O, Shaposhnikova, N A

“…The most significant complication of cirrhosis is portal hypertension syndrome. Varicose veins of the esophagus and stomach diagnosed in 50 - 80% of patients…”
Get more information

Enhancement of antiradical properties of dihydroquercetin by nitrosation by Gogotov, A. F., Kanitskaya, L. V., Hai, Dam Thi Thanh, Ostroukhova, L. A., Tai, Do Chiem, Bitukheeva, E. A., Shaposhnikova, A. N., Babkin, V. A., Stankevich, V. K.

“…Dihydroquercetin was converted to nitroso derivative by treatment with nascent nitrous acid in aqueous solution. The chemical structure of the synthesized…”
Get full text

Features of the HCV-infection in the elderly patients by Bakulin, I G, Shaposhnikova, N A, Koviazina, I O, Golovanova, E V, Vinnitskaia, E V

“…The problem of chronic HCV-infection in the elderly patients is poorly known. During the HCV-infection and progression of fibrosis in chronic liver diseases…”
Get more information

Realities and prospects for the use of cell technologies for the treatment of chronic diffuse liver diseases by Lazebnik, L B, Golovanova, E V, Slupskaia, V A, Trubitsina, I E, Kniazev, O V, Shaposhnikova, N A

“…Chronic liver disease (CLD) leads to disability annually hundreds of thousands of patients worldwide. Originating as a rule, at a young age (20-40 years), they…”
Get more information

Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis by Golovanova, E V, Vinnitskaia, E V, Shaposhnikova, N A, Petrakov, A V, Mel'kina, E S

“…Liver damage causes serious metabolic disorders, immune response, detoxification functions and antimicrobial protection. Therefore, the problem of finding new…”
Get more information

Liver cirrhosis of alcoholic etiology complicated by the spontaneous bacterial peritonitis by Vinnitskaia, E V, Shaposhnikova, N A, Chikunova, B Z, Toporkov, A S, Kim, O D

“…The case of spontaneous bacterial peritonitis (SBP) in the patient, with alcoholic cirrhosis, is presented in the article. Clinical observation demonstrates…”
Get more information